Schizophrenia is a complex genetic disorder with fairly high heritability. Although it has been reported that schizophrenia has high inheritance, the molecular pathogenesis of schizophrenia remains ...

Generally, the pathophysiology of schizophrenia is believed to be determined by imbalances in neurotransmitters, in particular dopamine and serotonin, and in four neural pathways in the brain ...

it is crucial to develop a better understanding of schizophrenia pathophysiology, as well as possible methods of preventing and managing the disorder. This article explores the potential link ...

Given the growing clinical and postmortem evidence implicating abnormal neurodevelopment in the pathogenesis of schizophrenia, the olfactory system may therefore hold special promise for ...

I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community. Historically ...

Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from 1-year open-label extension (OLE) trial now expected in December 2024 – ...

Caplyta (lumateperone) was approved for the treatment of schizophrenia in 2019 and for depressive episodes linked to bipolar I or bipolar II disorder (bipolar depression) in 2021. Caplyta can be ...

Schizophrenia is a multifactorial disorder. Viewing it through the lens of a single construct is futile. The role of genetics in the pathophysiology of schizophrenia cannot be overemphasised.

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Hi. I'm Michele Hammer and I have schizophrenia. Schizophrenia is a mental illness that changes the way you think, feel, and act. It's broken down into three separate categories, positive ...

metabolomic and transcriptomic biomarkers at the intersection of schizophrenia pathophysiology and ANAVEX3-71’s novel, dual mechanism of action, with the goal of addressing the large unmet need ...